Axon Enterprise Inc. (NASDAQ:AXON) stock fell in Friday’s premarket trading after the company reported weaker-than-expected third-quarter results and cut its 2026 revenue outlook due to delayed drone deployments.
The stock also fell 9.81% Thursday.
Separately, Axon announced an additional $1.2 billion investment in drone maker Skydio, bringing its total investment to $5.2 billion.
Axon reported adjusted earnings of $1.72 per share, missing Wall Street’s estimate of $1.88.
Revenue rose 28% year over year to $908.55 million, below the $937.59 million estimate.
Adjusted gross margin reached 59.2%. Higher memory costs are expected to pressure margins by about 50 basis points in 2026.
Meanwhile, bookings for Dedrone, 911, Fūsus and AI more than doubled to over $1 billion.
Axon lowered its 2026 revenue forecast to $3.61 billion-$3.63 billion from $3.67 billion-$3.725 billion. Analysts expected $3.699 billion.
Management blamed procurement delays, funding uncertainty, installation schedules and regulatory approvals rather than weaker demand.
Despite these setbacks, Axon expects annual revenue growth above 30% for the fifth consecutive year.
The company also cut its free cash flow forecast to $350 million-$400 million from $450 million, citing higher inventory spending.
Axon expects fourth-quarter revenue of $990 million-$1.01 billion, below the $1.061 billion estimate.
See More: Top Value Stocks
Software and Services revenue jumped 43% to $437 million. Annual recurring revenue rose 40% to $1.8 billion.
Connected Devices revenue increased 16% to $472 million, while Platform Solutions revenue surged 106% to $125 million.
Meanwhile, Axon’s AI products surpassed $100 million in annual recurring revenue in less than two years.
The company also introduced Axon Body 5, featuring 25 times the processing power of its predecessor.
Axon’s additional $1.2 billion investment increased its fully diluted ownership in Skydio to 37%.
The agreement gives Axon exclusive distribution rights for Skydio’s public safety drones in the U.S. and Canada.
Axon also raised $1.15 billion through convertible securities to help fund the investment.
Meanwhile, the company increased inventory by more than $100 million during the quarter to protect against supply disruptions.
Management expects inventory spending to normalize by early 2027. However, higher memory costs could remain a headwind through 2028.
AXON Price Action: Axon Enterprise shares were down 9.11% at $347.69 during premarket trading on Friday. The stock is trading near its 52-week low of $339.01, according to Benzinga Pro data.
Photo via Shutterstock